Cancer mortality down 20 percent from 1991 peak
As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately… read more.
As of 2009, the overall death rate for cancer in the United States had declined 20 percent from its peak in 1991, translating to the avoidance of approximately… read more.
For nearly a decade, breast cancer researchers studying the hormone therapy tamoxifen have been divided as to whether genetic differences in liver enzymes affect the drug’s effectiveness and… read more.
Researchers have shown in the laboratory how a ‘transcription factor’ causes breast cancer cells to develop an aggressive subtype that lacks sensitivity to oestrogen and does not respond… read more.
A new analysis has found that lumpectomy plus radiation for early breast cancer may provide patients with a better chance of survival than mastectomy.
Prostate cancer patients receiving the costly treatment known as proton radiotherapy experienced minimal relief from side effects such as incontinence and erectile dysfunction, compared to patients undergoing a… read more.
A new study comparing outcomes among prostate cancer patients treated with surgery versus radiotherapy found differences in urinary, bowel and sexual function after short-term follow-up, but those differences… read more.
FDA Highlights by Bruce Sylvester – Women with ovarian cancer and diabetes who took metformin for their diabetes have achieved a better survival rate than patients who did… read more.
by Marybeth Burke – Women treated for childhood cancer with chest radiation therapy have a high risk of developing breast cancer at a young age, comparable to that… read more.
by Edel O’Connell reporting on a presentation by Dr. Soon Wei Neoh.
by Bruce Sylvester – taken from The British Medical Journal (BMJ) – Contradicting previous research, researchers from a study of over 44,000 women in England report that treatment… read more.
The European Society for Medical Oncology (ESMO) has awarded ESMO Designated Center of Integrated Oncology and Palliative Care accreditation to 16 new oncology centres.
by Zara Qadir reporting on the presentation by Professor Petra Thürmann (pictured) from the Philipp Klee-Institute of Clinical Pharmacology at the HELIOS Klinikum Wuppertal in Germany.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.